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HIV/AIDS, tuberculosis (TB), and malaria (ATM) are 3
major global public health threats that undermine develop-
ment in low- and middle-income countries [1].
Approximately 5 million lives are lost annually as a result
oftheseinfections,withsubstantialhumanitarian,economic,
and social impact, which is still not fully measured [1]. The
three infections are not only associated with poverty but also
occur in the same geographic zone and have major public
health implications [2]. The consequences of interactions
between the diseases are particularly serious for reproductive
health. They often intersect in pregnancy, resulting in poor
maternal and fetal outcomes. As access to their treatment
is increasing in low-income countries and new and cheaper
alternative drugs are being deployed, there is also the po-
tential for interactions between their treatments, which
aﬀects the eﬃcacy of each drug.
Theco-infectedpregnantwomenareataveryhighriskof
anaemia and infection of the placenta; hence a considerable
proportion of children born to women with HIV, TB and
malaria infection have low birth weight and are more likely
to die during infancy [3–5]. Also, there is the risk of mother
to child transmission of the infections.
Globally, an estimated 342,900 maternal deaths occur
annually and more than 99% of these occur in low- and
middle-income countries [6]. It is barely four years to the
target for the attainment of Millennium Development Goal
(MDG) 5, which seeks to reduce the maternal mortality
ratio (MMR) by three-fourths. The three leading causes
of these deaths have remained hemorrhage, infections, and
hypertensive disorders [6, 7]. Local and regional variations
do exist, however in sub-Saharan Africa, and Asia, infection
as a result of HIV epidemic, resurgence of TB, and the
ubiquitous malaria is a major cause [7].
Malaria is the most common of the three infections and
it is estimated that over 50 million women are exposed to
the risk of malaria in pregnancy annually [8]. Malaria infec-
tion in pregnancy results in substantial maternal, fetal, and
infant morbidity and mortality, accounting for 75000–
200000 infant deaths yearly [9]. It causes diverse adverse
pregnancy outcomes, including maternal anaemia and low
birth weight due to preterm delivery and fetal growth
restriction. Pregnant women are more susceptible than non-
pregnantwomentomalaria,andthissusceptibilityisgreatest
in the ﬁrst and second pregnancy. Susceptibility to malaria
during pregnancy probably represents a combination of im-
munological and hormonal changes associated with preg-
nancy, combined with the unique ability of a subset of
infected erythrocytes to sequester in the placenta [9].
In the same settings of malaria, HIV infection has con-
tinued to remain a major public health challenge and thus
have been described as a deadly combination, especially in
pregnancy[5].AvailableevidenceconﬁrmsthatHIV-positive
women are at greater risk of maternal death and morbidity
[10]. In high burden areas, which also have the highest
rates of maternal mortality, HIV is beginning to reverse the
progressinsafemotherhood[10].HIV-infectedwomencon-
front stigma, discrimination, and violence that compromise
their health and may put their lives and their oﬀspring at
risk. In some situations they have been refused services for
labour and delivery and/or have been given substandard2 Journal of Pregnancy
services [10]. The estimates of the contribution of HIV and
TB infections to overall maternal mortality vary greatly by
region [11].AllarecertainlyunderestimatesbecausetheHIV
status of many women is not known, and HIV contributes
to increased mortality related to pregnancy even beyond 42
days postpartum, the period during which maternal health
is calculated [5]. Areas with high HIV prevalence and high
maternal mortality also have lower rates of antiretroviral
treatment and higher levels of diseases and conditions that
can be exacerbated by both HIV infection and pregnancy
[12].
There are several ways in which HIV is believed to con-
tribute to elevated maternal mortality and morbidity. HIV
infection is associated with an increase in direct complica-
tions such as anaemia, postpartum haemorrhage, and puer-
peral sepsis [11, 13]. In addition, both HIV infection and
pregnancy may increase susceptibility to other diseases that
aﬀect pregnancy outcome such as tuberculosis, malaria, and
pneumonia[9,12,14].Pregnancyitselfrenderswomenmore
vulnerable to acquiring HIV infection. Finally, women who
are HIV positive and pregnant may receive lower quality care
for both pregnancy and HIV due to discrimination by health
care providers [10].
Globally, tuberculosis has increased over the past two
decades, with the largest burden of disease borne by impov-
erished communities in the same geographic areas where
malaria and HIV are endemic [13]. While it is known that
the deterioration in socioeconomic conditions, poorly func-
tioningnationaltuberculosis-controlprogrammes,andmul-
tidrug resistance have to varying extents contributed to
the resurgence of tuberculosis, the main driving force has
been the pandemic of HIV-1 infection [13]. A considerable
overlap exists in the age groups commonly aﬀected by
tuberculosis and HIV [15, 16].
The current understanding of the human immune re-
sponse to malaria, HIV, and TB leads us to expect the three
infections to inﬂuence the clinical outcome of each other as
well as that of pregnancy. Each of the infections is expected
to accelerate the progression of the other and thus impacts
heavily on pregnancy, not only in terms of the morbidity
and mortality but also on the transmission of the infections
to the unborn child [3–5, 8]. The eﬀects of HIV infection
on maternal health are superimposed on those of malaria
in low-income countries, where over 1 million pregnancies
annually are complicated by malaria-HIV coinfection [3,
4]. With the documented 20–30% rate of HIV and TB
coinfection in these same settings, it is safe to state that at
any given time, more than 300,000 pregnancies are triply
infected by HIV, malaria, and TB. Such pregnancies are
associated with higher malaria parasite densities, HIV viral
load, and a higher risk of maternal anaemia, low birth-
weight, and perinatal and infants morbidity and mortality
[3–5, 8]. While HIV and TB infection aﬀects all pregnancies,
the HIV-associated risk of malaria is consistently greater in
multigravida [3–5, 8]. Furthermore there are risks of poorer
responsetomalariaprophylaxisandtreatmentwithHIVand
also adverse drug reaction during pregnancy [9].
At the clinical level, the interactions between the infec-
tions are complex and bidirectional [9]. Although the
morbidity and mortality attributable to each infection in the
presence of the other are not fully understood, interactions
that are likely to have signiﬁcant clinical consequences have
been described [9, 14]. Each infection exacerbates the other:
Malarial and TB infections of the placenta increase placental
viral load, thus increasing the risk of vertical transmission
of HIV. On the other hand, HIV-infected pregnant women
have reduced antimalarial and TB immunity and higher
prevalence rates of malaria and TB [15–17, 16]. TB-infected
pregnant women are more susceptible to HIV and malaria
infection compared to their noninfected counterparts [3–5].
Though the burden and the consequences of the inter-
action and intersection of the three infections in pregnancy
are frightening, the real tragedy is the failure to make low
cost and eﬀective interventions tools available to the women.
These tools and interventions include prevention of mother
to child transmission of HIV (PMTCT), Intermittent Pro-
phylactic Therapy (IPTp), Long-Lasting Insecticide Treated
Nets (LLINs), and infection control practices (ICPs). The
prize of the slow or nondeployment of evidence-based and
lowcosttoolsistheavoidablehumantragedycalledmaternal
and infant mortality.
The regions with high HIV, malaria, and TB burden
further suﬀer from the world’s most pronounced crisis in
human resources for health [18]. This shortage is com-
poundedbythediscussedinfectionsespeciallytheHIV/AIDS
pandemic. It is therefore only reasonable to consider human
resource issues while trying to prevent and control the infec-
tions. One strategy that has been suggested and evaluated is
the reassignment of clinical roles by shifting tasks to diﬀerent
cadres of health workers. For examples nurses and midwives
may become involved in prescribing drugs, lay counselors
involved in testing, and patients may be engaged in taking
over some elements of their own care [18].
Halting and reversing the human tragedy due to the
deadly trio of HIV, malaria, and TB requires not only the
deployment of the evidence-based prevention and man-
agement tools already available but also the integration of
various services into the existing maternal and child health
care services utilizing available human resource. However,
the best model for deployment of such tools in low-in-
come countries has not yet been identiﬁed. Operational
researchisthereforerequiredtodeterminethebestmodelsof
integration and deployment of these services through testing
of existing models
EﬀortataddressingthechallengeofHIV,TB,andmalaria
in pregnancy should address all sexual and reproductive
health services as one entity rather than in units. Many of
the interventions that would improve their outcomes such as
familyplanning,antenatalanddeliverycare,includingaccess
to emergency obstetric services are general issues applying to
all women. The integration of TB, malaria, and HIV services
into existing maternal, newborn, and child health care pro-
grammes and task shifting seems to be the ideal strategy to
reverse the human toll due to the three infections.
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